CLINICAL TRIALS PROFILE FOR NIRAPARIB TOSYLATE
✉ Email this page to a colleague
All Clinical Trials for niraparib tosylate
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT04030559 ↗ | Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects | Recruiting | Janssen, LP | Phase 2 | 2020-02-25 | This phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body (localized) and alterations in deoxyribonucleic acid (DNA) repair pathways. Niraparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. |
NCT04030559 ↗ | Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects | Recruiting | National Cancer Institute (NCI) | Phase 2 | 2020-02-25 | This phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body (localized) and alterations in deoxyribonucleic acid (DNA) repair pathways. Niraparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. |
NCT04030559 ↗ | Niraparib Before Surgery in Treating Patients With High Risk Localized Prostate Cancer and DNA Damage Response Defects | Recruiting | University of California, Davis | Phase 2 | 2020-02-25 | This phase II trial studies how well niraparib, when given before surgery, works in treating patients with high risk prostate cancer that has not spread to other parts of the body (localized) and alterations in deoxyribonucleic acid (DNA) repair pathways. Niraparib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for niraparib tosylate
Condition Name
Condition Name for niraparib tosylate | |
Intervention | Trials |
Prognostic Stage IIB Breast Cancer AJCC v8 | 1 |
Anatomic Stage IA Breast Cancer AJCC v8 | 1 |
Stage IIIB Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for niraparib tosylate
Trials by Country
Clinical Trial Progress for niraparib tosylate
Clinical Trial Phase
Clinical Trial Sponsors for niraparib tosylate
Sponsor Name